However, it is in marked contrast to the current circulating tumor DNA (ctDNA) literature which suggests that pre-existing or de novo generated RAS and de novo EGFR mutations are the primary cause of SR development in up to 96% of CRCs [9, 15, 17, 58, 88–93]. This evidence concerns the gene EGFR and neoplasm.